Lamivudine prophylaxis prevents hepatitis B virus reactivation in anti-HBc positive patients under rituximab for non-Hodgkin lymphoma

Authors:

Abstract
No abstract available
Funding Information
  • Ministero della Salute (2018–105/01)
  • Gilead Sciences
  • AbbVie
  • GlaxoSmithKline
  • Meso Scale Diagnostics

This publication has 24 references indexed in Scilit: